Literature DB >> 2911806

Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia.

C Joborn1, J Hetta, L Lind, J Rastad, G Akerström, S Ljunghall.   

Abstract

Self-rated psychiatric symptoms were investigated in 30 patients referred for surgery because of primary hyperparathyroidism (HPT) (serum calcium, 2.87 +/- 0.21 mmol/L) in 38 subjects detected in a health screening, with 15 years of mild hypercalcemia and probable HPT (serum calcium, 2.66 +/- 0.09 mmol/L), and in 38 normocalcemic control subjects. The psychiatric symptomatology was evaluated by use of the Hopkins Symptom Checklist (HSCL-56), a self-rating symptom scale. The patients with verified HPT had the highest mean HSCL score, 89.1 +/- 20.1 before surgery, compared with 76.6 +/- 17.0 (p less than 0.01) in the health survey hypercalcemic patients and 73.8 +/- 16.0 (p less than 0.001) in the controls. The factors for anxiety, depression, and cognitive symptoms were the most pronounced in the HPT patients and were also increased among the mildly hypercalcemic persons of the health survey, compared with the controls. Somatic symptoms such as headache, back pain, chest pain, and weakness were equally common in HPT and in the controls, and measurements of isometric muscle strength of knee extension did not demonstrate reduction of muscle strength in the health survey hypercalcemic patients. Follow-up of the HPT patients 1 year after parathyroid surgery revealed a marked improvement in mental health (HSCL score 73.2 +/- 13.7, p less than 0.001). In the health survey hypercalcemic patients, neither the psychiatric symptomatology nor the muscle strength were influenced by 6 months of oral vitamin D therapy (alphacalcidol). The results demonstrate that psychiatric symptoms are experienced frequently by patients with HPT and minimum to moderate increases in the serum calcium level and that these disturbances are reversed by parathyroid surgery.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2911806

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  18 in total

Review 1.  Parathyroidectomy for asymptomatic primary hyperparathyroidism (PHPT): is it worth the risk?

Authors:  J Rastad
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

2.  Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism.

Authors:  Cornelia M E Dotzenrath; Ana Karena Kaetsch; Henrich Pfingsten; Kenko Cupisti; Norbert Weyerbrock; Alexander Vossough; Pablo E Verde; Christian Ohmann
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

3.  Bilateral internal jugular venous sampling for parathyroid hormone determination in patients with nonlocalizing primary hyperparathyroidism.

Authors:  Raul Alvarado; Goswin Meyer-Rochow; Mark Sywak; Leigh Delbridge; Stan Sidhu
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 4.  Primary hyperparathyroidism, cognition, and health-related quality of life.

Authors:  Laura H Coker; Kashemi Rorie; Larry Cantley; Kimberly Kirkland; David Stump; Nicole Burbank; Terry Tembreull; Jeff Williamson; Nancy Perrier
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

5.  Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms.

Authors:  A Trombetti; E R Christ; C Henzen; G Gold; M Brändle; F R Herrmann; C Torriani; F Triponez; M Kraenzlin; R Rizzoli; C Meier
Journal:  J Endocrinol Invest       Date:  2016-01-07       Impact factor: 4.256

6.  Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture.

Authors:  S Ljunghall; P Hellman; J Rastad; G Akerström
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 7.  Asymptomatic primary hyperparathyroidism.

Authors:  B J Harrison; M H Wheeler
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 8.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

9.  Surgery for sporadic primary hyperparathyroidism in the elderly.

Authors:  U Ohrvall; G Akerström; S Ljunghall; E Lundgren; C Juhlin; J Rastad
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

10.  Improvement of sleep disturbance and insomnia following parathyroidectomy for primary hyperparathyroidism.

Authors:  Sara E Murray; Priya R Pathak; Sarah C Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.